Aileron Therapeutics to Host Key Opinion Leader Event on February 15, 2024

February 1, 2024

https://www.globenewswire.com/news-release/2024/02/01/2822483/28652/en/Aileron-Therapeutics-to-Host-Key-Opinion-Leader-Event-on-February-15-2024.html

WALTHAM, Mass., Feb. 01, 2024 (GLOBE NEWSWIRE) — Aileron Therapeutics, Inc. (“Aileron”) (NASDAQ:ALRN), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines to address significant unmet medical needs in orphan pulmonary and fibrosis indications, today announced that it will host a virtual key opinion leader event titled, “Clinical Perspectives on Treating Idiopathic Pulmonary Fibrosis” on Thursday, February 15, 2024, from 4:30 to 5:30 p.m. ET.

Read more at globenewswire.com

Related news for (ALRN)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.